Lexiva co-inventor appointed R&D president
This article was originally published in Scrip
Executive Summary
Dr Eric Furfine has been appointed president of research and development at Eleven Biotherapeutics, a US company developing innovative protein-based therapeutics. Dr Furfine will replace interim R&D president Dr Burt Adelman, who will continue to serve as scientific advisor at the company.